Position in OGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,624
+$787 QoQ
Shares Held
120
+300.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#435
of 626 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Washington Trust Advisors, Inc. holds $19,377,717 across 13 Drug Manufacturers - General names. OGN ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
44,934 | $11,411,887 | |
| 2 | ABBV |
AbbVie Inc.
|
15,278 | $3,844,555 | |
| 3 | LLY |
ELI LILLY & Co
|
968 | $1,161,048 | |
| 4 | PFE |
Pfizer Inc
|
43,407 | $1,045,240 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,790 | $1,001,015 | |
| 6 | AMGN |
Amgen Inc
|
796 | $288,247 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,887 | $281,588 | |
| 8 | NVS |
Novartis AG
|
736 | $115,345 |
All Filings in OGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,624 | 120 | Shares | Sole | 2026-07-29 | |
| 2022-12-31 | $837 | 30 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,188 | 179 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $6,007 | 178 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $17,708 | 507 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $17,691 | 581 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||